Cargando…

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe

Observational data over 15 years of rotavirus vaccine introduction in Belgium have indicated that rotavirus hospitalisations in children aged <5 years plateaued at a higher level than expected, and was followed by biennial disease peaks. The research objective was to identify factors influencing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Standaert, Baudouin, Benninghoff, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879258/ https://www.ncbi.nlm.nih.gov/pubmed/35216018 http://dx.doi.org/10.3390/v14020425

Ejemplares similares

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2020)

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country
por: Standaert, Baudouin
Publicado: (2023)

The Value of Rotavirus Vaccination in Europe: A Call for Action
por: Cohen, Robert, et al.
Publicado: (2022)

Publisher Correction: The Value of Rotavirus Vaccination in Europe: A Call for Action
por: Cohen, Robert, et al.
Publicado: (2022)

Improving the Hospital Quality of Care during Winter Periods by Optimizing Budget Allocation Between Rotavirus Vaccination and Bed Expansion
por: Dort, Thibaut, et al.
Publicado: (2017)

Rotavirus vaccination and intussusception: a paradigm shift?
por: Vetter, Volker, et al.
Publicado: (2020)

Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2015)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines
por: Pereira, Priya, et al.
Publicado: (2020)

Measuring indirect effects of rotavirus vaccine in low income countries
por: Bennett, Aisleen, et al.
Publicado: (2016)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Role of healthcare practitioners in rotavirus disease awareness and vaccination – insights from a survey among caregivers
por: Benninghoff, Bernd, et al.
Publicado: (2019)

Established and new rotavirus vaccines: a comprehensive review for healthcare professionals
por: Vetter, Volker, et al.
Publicado: (2021)

The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005–2012)
por: Standaert, Baudouin, et al.
Publicado: (2016)

Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis
por: Standaert, Baudouin, et al.
Publicado: (2015)

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014)

Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UK
por: Heinsbroek, Ellen, et al.
Publicado: (2019)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
por: Marijam, Alen, et al.
Publicado: (2022)

Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium
por: Standaert, B, et al.
Publicado: (2015)

Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
por: Lee, Benjamin
Publicado: (2020)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination
por: Steele, A. Duncan, et al.
Publicado: (2016)

Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States
por: Weycker, Derek, et al.
Publicado: (2014)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990
por: Standaert, Baudouin
Publicado: (2023)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Letter to the editor concerning the article ‘Association between rotavirus vaccination and risk of intussusception among neonates and infants: a systematic review and meta-analysis’ (JAMA Netw Open. 2019;2(10):e1912458)
por: Benninghoff, Bernd, et al.
Publicado: (2020)

Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review
por: Gruber, Joann F., et al.
Publicado: (2017)

Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines
por: Chung, Ju-Young, et al.
Publicado: (2015)

Rotavirus infections and their genotype distribution in Rwanda before and after the introduction of rotavirus vaccination
por: Kabayiza, Jean-Claude, et al.
Publicado: (2023)

Intussusception after Rotavirus Vaccine Introduction in India
por: Reddy, Samarasimha Nusi, et al.
Publicado: (2020)

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?
por: Standaert, Baudouin, et al.
Publicado: (2014)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
por: Steele, A.D., et al.
Publicado: (2019)

Low Prevalence of Rotavirus and High Prevalence of Norovirus in Hospital and Community Wastewater after Introduction of Rotavirus Vaccine in Nicaragua
por: Bucardo, Filemón, et al.
Publicado: (2011)

Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries
por: Mooney, Jessica, et al.
Publicado: (2022)

2. How is the economic assessment of vaccines performed today?
por: Standaert, Baudouin, et al.
Publicado: (2017)

Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination
por: Standaert, Baudouin, et al.
Publicado: (2017)

Norovirus and rotavirus in children hospitalised with diarrhoea after rotavirus vaccine introduction in Burkina Faso
por: Rönnelid, Y., et al.
Publicado: (2020)

3. How comprehensive can we be in the economic assessment of vaccines?
por: Standaert, Baudouin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_grj44kfk66vga5fk2jgi3b2t2f